Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The acute extracellular flux (XF) assay to assess compound effects on mitochondrial function.

Wang R, Novick SJ, Mangum JB, Queen K, Ferrick DA, Rogers GW, Stimmel JB.

J Biomol Screen. 2015 Mar;20(3):422-9. doi: 10.1177/1087057114557621. Epub 2014 Nov 7.

PMID:
25381255
2.

Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1.

Stapleton CM, Mashek DG, Wang S, Nagle CA, Cline GW, Thuillier P, Leesnitzer LM, Li LO, Stimmel JB, Shulman GI, Coleman RA.

PLoS One. 2011 Apr 20;6(4):e18932. doi: 10.1371/journal.pone.0018932.

3.

Validation of an optical microplate label-free platform in the screening of chemical libraries for direct binding to a nuclear receptor.

Vela L, Lowe PN, Gerstenmaier J, Laing LG, Stimmel JB, Orband-Miller LA, Martin JJ.

Assay Drug Dev Technol. 2011 Oct;9(5):532-48. doi: 10.1089/adt.2010.0345. Epub 2011 Mar 25.

PMID:
21438675
4.

γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer.

Campbell SE, Rudder B, Phillips RB, Whaley SG, Stimmel JB, Leesnitzer LM, Lightner J, Dessus-Babus S, Duffourc M, Stone WL, Menter DG, Newman RA, Yang P, Aggarwal BB, Krishnan K.

Free Radic Biol Med. 2011 May 15;50(10):1344-54. doi: 10.1016/j.freeradbiomed.2011.02.007. Epub 2011 Feb 16.

PMID:
21335085
5.

Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells.

Campbell SE, Musich PR, Whaley SG, Stimmel JB, Leesnitzer LM, Dessus-Babus S, Duffourc M, Stone W, Newman RA, Yang P, Krishnan K.

Nutr Cancer. 2009;61(5):649-62. doi: 10.1080/01635580902825654.

PMID:
19838939
6.

Human PXR forms a tryptophan zipper-mediated homodimer.

Noble SM, Carnahan VE, Moore LB, Luntz T, Wang H, Ittoop OR, Stimmel JB, Davis-Searles PR, Watkins RE, Wisely GB, LeCluyse E, Tripathy A, McDonnell DP, Redinbo MR.

Biochemistry. 2006 Jul 18;45(28):8579-89.

7.

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.

Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, Shureiqi I.

Oncogene. 2006 Feb 23;25(8):1225-41.

8.

The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.

Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9968-73. Epub 2003 Aug 8.

9.

Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.

Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, Stimmel JB.

Biochemistry. 2003 Aug 12;42(31):9278-87. Erratum in: Biochemistry. 2006 Oct 3;45(39):12194.

PMID:
12899614
10.

The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.

Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Y, Gribble GW, Leesnitzer LM, Stimmel JB, Willson TM, Rosen E, Sporn MB.

Clin Cancer Res. 2003 Jul;9(7):2798-806.

11.

Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.

Thurmond LM, Stimmel JB, Ingram AC, Ryan CH, Murray DM, Eberwein DJ, Witherspoon SM, Knick VC.

Cancer Immunol Immunother. 2003 Jul;52(7):429-37. Epub 2003 Apr 15.

PMID:
12695858
12.

Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.

Thuillier P, Brash AR, Kehrer JP, Stimmel JB, Leesnitzer LM, Yang P, Newman RA, Fischer SM.

Biochem J. 2002 Sep 15;366(Pt 3):901-10.

13.

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG.

Biochemistry. 2002 May 28;41(21):6640-50.

PMID:
12022867
14.

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.

Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB.

Nature. 2002 Feb 14;415(6873):813-7.

PMID:
11845213
15.

Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.

Iannone MA, Consler TG, Pearce KH, Stimmel JB, Parks DJ, Gray JG.

Cytometry. 2001 Aug 1;44(4):326-37.

16.

Site-specific conjugation on serine right-arrow cysteine variant monoclonal antibodies.

Stimmel JB, Merrill BM, Kuyper LF, Moxham CP, Hutchins JT, Fling ME, Kull FC Jr.

J Biol Chem. 2000 Sep 29;275(39):30445-50.

17.

Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.

Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA.

J Biol Chem. 2000 May 19;275(20):15122-7.

18.

Bile acids: natural ligands for an orphan nuclear receptor.

Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM.

Science. 1999 May 21;284(5418):1365-8.

19.

Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.

Stimmel JB, Kull FC Jr.

Nucl Med Biol. 1998 Feb;25(2):117-25.

PMID:
9468026
20.

Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogues, and a novel terpyridine acyclic chelator.

Stimmel JB, Stockstill ME, Kull FC Jr.

Bioconjug Chem. 1995 Mar-Apr;6(2):219-25. Erratum in: Bioconjug Chem 1995 Jul-Aug;6(4):506.

PMID:
7599265
21.

Early responses of PC-12 cells to NGF and EGF: effect of K252a and 5'-methylthioadenosine on gene expression and membrane protein methylation.

Kujubu DA, Stimmel JB, Law RE, Herschman HR, Clarke S.

J Neurosci Res. 1993 Sep 1;36(1):58-65.

PMID:
8230321
23.

Evidence for an S-farnesylcysteine methyl ester at the carboxyl terminus of the Saccharomyces cerevisiae RAS2 protein.

Stimmel JB, Deschenes RJ, Volker C, Stock J, Clarke S.

Biochemistry. 1990 Oct 16;29(41):9651-9.

PMID:
2271607
24.

RAS2 protein of Saccharomyces cerevisiae is methyl-esterified at its carboxyl terminus.

Deschenes RJ, Stimmel JB, Clarke S, Stock J, Broach JR.

J Biol Chem. 1989 Jul 15;264(20):11865-73.

Supplemental Content

Loading ...
Support Center